Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline versus Zoely for premenstrual dysphoric disorder
ACTRN12623000496617Phase 2Recruiting
- Sponsor
- Monash University
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sertraline and nomegestrol acetate + estradiol in Premenstrual Dysphoric Disorder (PMDD) (2 arms), sponsored by Monash University. Primary endpoint: Change in Daily Record of Severity of Problems (DRSP) in the luteal phase. Started May 2024; status: recruiting.
02
Drugs
sertralinenomegestrol acetate + estradiol
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on ACTRN12623000496617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000496617.